PDB Short entry for 2LZX
HEADER    TOXIN                                   11-OCT-12   2LZX              
TITLE     SOLUTION NMR STRUCTURE OF ASTEROPSIN B FROM A MARINE SPONGE ASTEROPUS 
TITLE    2 SP.                                                                  
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: ASTEROPSIN B;                                              
COMPND   3 CHAIN: A                                                             
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: ASTEROPUS;                                      
SOURCE   3 ORGANISM_TAXID: 350938                                               
KEYWDS    KNOTTIN, SPONGE, TOXIN                                                
EXPDTA    SOLUTION NMR                                                          
NUMMDL    20                                                                    
AUTHOR    H.LI,J.J.BOWLING,M.T.HAMANN,J.H.JUNG                                  
REVDAT   3   14-JUN-23 2LZX    1       REMARK                                   
REVDAT   2   25-DEC-19 2LZX    1       SEQRES LINK                              
REVDAT   1   23-OCT-13 2LZX    0                                                
JRNL        AUTH   H.LI,J.J.BOWLING,M.SU,J.HONG,B.LEE,H.KANG,M.T.HAMANN,        
JRNL        AUTH 2 J.H.JUNG                                                     
JRNL        TITL   SPONGE DERIVED LINEAR KNOTTINS AS A NOVEL SCAFFOLD FOR ORAL  
JRNL        TITL 2 PEPTIDE DRUG ADMINISTRATION                                  
JRNL        REF    TO BE PUBLISHED                                              
JRNL        REFN                                                                
REMARK   2                                                                      
REMARK   2 RESOLUTION. NOT APPLICABLE.                                          
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : CNS 1.3, CNS 1.3                                     
REMARK   3   AUTHORS     : BRUNGER, ADAMS, CLORE, GROS, NILGES AND READ         
REMARK   3                 (CNS), BRUNGER, ADAMS, CLORE, GROS, NILGES AND       
REMARK   3                 READ (CNS)                                           
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: NULL                                      
REMARK   4                                                                      
REMARK   4 2LZX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-OCT-12.                  
REMARK 100 THE DEPOSITION ID IS D_1000103033.                                   
REMARK 210                                                                      
REMARK 210 EXPERIMENTAL DETAILS                                                 
REMARK 210  EXPERIMENT TYPE                : NMR                                
REMARK 210  TEMPERATURE           (KELVIN) : 298                                
REMARK 210  PH                             : 7.0                                
REMARK 210  IONIC STRENGTH                 : NULL                               
REMARK 210  PRESSURE                       : AMBIENT                            
REMARK 210  SAMPLE CONTENTS                : 10 MM ABU8-2, DMSO-D6              
REMARK 210                                                                      
REMARK 210  NMR EXPERIMENTS CONDUCTED      : 2D DQF-COSY; 2D 1H-1H TOCSY; 2D    
REMARK 210                                   1H-1H NOESY; 2D 1H-13C HSQC        
REMARK 210  SPECTROMETER FIELD STRENGTH    : 600 MHZ; 500 MHZ                   
REMARK 210  SPECTROMETER MODEL             : INOVA                              
REMARK 210  SPECTROMETER MANUFACTURER      : VARIAN                             
REMARK 210                                                                      
REMARK 210  STRUCTURE DETERMINATION.                                            
REMARK 210   SOFTWARE USED                 : NULL                               
REMARK 210   METHOD USED                   : SIMULATED ANNEALING                
REMARK 210                                                                      
REMARK 210 CONFORMERS, NUMBER CALCULATED   : 200                                
REMARK 210 CONFORMERS, NUMBER SUBMITTED    : 20                                 
REMARK 210 CONFORMERS, SELECTION CRITERIA  : STRUCTURES WITH THE LOWEST         
REMARK 210                                   ENERGY                             
REMARK 210                                                                      
REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1                   
REMARK 210                                                                      
REMARK 210 REMARK: NULL                                                         
REMARK 215                                                                      
REMARK 215 NMR STUDY                                                            
REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION           
REMARK 215 NMR DATA.  PROTEIN DATA BANK CONVENTIONS REQUIRE THAT                
REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON              
REMARK 215 THESE RECORDS ARE MEANINGLESS.                                       
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1                                                       
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC                         
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A                                     
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: TORSION ANGLES                                             
REMARK 500                                                                      
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-           
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400            
REMARK 500                                                                      
REMARK 500  M RES CSSEQI        PSI       PHI                                   
REMARK 500  1 PHE A  14      -45.02   -148.72                                   
REMARK 500  1 TYR A  15       74.20   -115.56                                   
REMARK 500  2 PHE A  14      -44.97   -148.91                                   
REMARK 500  2 TYR A  15       74.16   -115.61                                   
REMARK 500  3 PHE A  14      -45.01   -148.80                                   
REMARK 500  3 TYR A  15       74.21   -115.58                                   
REMARK 500  4 PHE A  14      -45.20   -149.03                                   
REMARK 500  4 TYR A  15       74.16   -115.49                                   
REMARK 500  5 PHE A  14      -45.07   -148.90                                   
REMARK 500  5 TYR A  15       74.20   -115.57                                   
REMARK 500  6 PHE A  14      -45.13   -148.84                                   
REMARK 500  6 TYR A  15       74.18   -115.55                                   
REMARK 500  7 PHE A  14      -45.01   -149.09                                   
REMARK 500  7 TYR A  15       74.13   -115.67                                   
REMARK 500  8 PHE A  14      -44.96   -148.91                                   
REMARK 500  8 TYR A  15       73.99   -115.45                                   
REMARK 500  9 PHE A  14      -45.12   -148.95                                   
REMARK 500  9 TYR A  15       74.17   -115.64                                   
REMARK 500 10 PHE A  14      -45.02   -148.82                                   
REMARK 500 10 TYR A  15       74.27   -115.57                                   
REMARK 500 10 CYS A  17     -177.73    -69.96                                   
REMARK 500 11 PHE A  14      -45.01   -148.98                                   
REMARK 500 11 TYR A  15       74.20   -115.59                                   
REMARK 500 12 PHE A  14      -44.75   -149.03                                   
REMARK 500 12 TYR A  15       73.92   -115.47                                   
REMARK 500 13 PHE A  14      -45.01   -148.81                                   
REMARK 500 13 TYR A  15       74.05   -115.42                                   
REMARK 500 14 PHE A  14      -45.00   -148.94                                   
REMARK 500 14 TYR A  15       74.22   -115.63                                   
REMARK 500 15 PHE A  14      -45.05   -149.02                                   
REMARK 500 15 TYR A  15       74.10   -115.58                                   
REMARK 500 16 PHE A  14      -44.97   -148.80                                   
REMARK 500 16 TYR A  15       74.07   -115.44                                   
REMARK 500 17 PHE A  14      -44.94   -147.54                                   
REMARK 500 17 TYR A  15       74.20   -115.69                                   
REMARK 500 18 PHE A  14      -45.13   -149.06                                   
REMARK 500 18 TYR A  15       74.15   -115.58                                   
REMARK 500 19 PHE A  14      -44.86   -148.97                                   
REMARK 500 19 TYR A  15       74.07   -115.38                                   
REMARK 500 20 PHE A  14      -45.02   -148.78                                   
REMARK 500 20 TYR A  15       74.22   -115.69                                   
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 900                                                                      
REMARK 900 RELATED ENTRIES                                                      
REMARK 900 RELATED ID: 18783   RELATED DB: BMRB                                 
DBREF  2LZX A    1    37  PDB    2LZX     2LZX             1     37             
SEQRES   1 A   37  PCA GLY CYS ALA PHE GLU GLY GLU SER CYS ASN VAL GLU          
SEQRES   2 A   37  PHE TYR PRO CYS CYS PRO GLY LEU GLY LEU THR CYS ILE          
SEQRES   3 A   37  PRO GLY ASN PRO ASP GLY THR CYS TYR TYR LEU                  
MODRES 2LZX PCA A    1  GLN  PYROGLUTAMIC ACID                                  
HET    PCA  A   1      14                                                       
HETNAM     PCA PYROGLUTAMIC ACID                                                
FORMUL   1  PCA    C5 H7 N O3                                                   
SHEET    1   A 3 SER A   9  ASN A  11  0                                        
SHEET    2   A 3 ASP A  31  TYR A  36 -1  O  GLY A  32   N  CYS A  10           
SHEET    3   A 3 LEU A  23  ILE A  26 -1  N  THR A  24   O  TYR A  35           
SSBOND   1 CYS A    3    CYS A   18                          1555   1555  2.03  
SSBOND   2 CYS A   10    CYS A   25                          1555   1555  2.03  
SSBOND   3 CYS A   17    CYS A   34                          1555   1555  2.03  
LINK         C   PCA A   1                 N   GLY A   2     1555   1555  1.34  
CISPEP   1 ILE A   26    PRO A   27          1        -0.10                     
CISPEP   2 ASN A   29    PRO A   30          1        -0.18                     
CISPEP   3 ILE A   26    PRO A   27          2        -0.02                     
CISPEP   4 ASN A   29    PRO A   30          2        -0.24                     
CISPEP   5 ILE A   26    PRO A   27          3        -0.12                     
CISPEP   6 ASN A   29    PRO A   30          3        -0.18                     
CISPEP   7 ILE A   26    PRO A   27          4        -0.12                     
CISPEP   8 ASN A   29    PRO A   30          4        -0.27                     
CISPEP   9 ILE A   26    PRO A   27          5        -0.12                     
CISPEP  10 ASN A   29    PRO A   30          5        -0.21                     
CISPEP  11 ILE A   26    PRO A   27          6        -0.08                     
CISPEP  12 ASN A   29    PRO A   30          6        -0.20                     
CISPEP  13 ILE A   26    PRO A   27          7        -0.12                     
CISPEP  14 ASN A   29    PRO A   30          7        -0.13                     
CISPEP  15 ILE A   26    PRO A   27          8        -0.15                     
CISPEP  16 ASN A   29    PRO A   30          8        -0.16                     
CISPEP  17 ILE A   26    PRO A   27          9        -0.24                     
CISPEP  18 ASN A   29    PRO A   30          9        -0.17                     
CISPEP  19 ILE A   26    PRO A   27         10        -0.01                     
CISPEP  20 ASN A   29    PRO A   30         10        -0.17                     
CISPEP  21 ILE A   26    PRO A   27         11        -0.11                     
CISPEP  22 ASN A   29    PRO A   30         11        -0.11                     
CISPEP  23 ILE A   26    PRO A   27         12        -0.08                     
CISPEP  24 ASN A   29    PRO A   30         12        -0.21                     
CISPEP  25 ILE A   26    PRO A   27         13        -0.04                     
CISPEP  26 ASN A   29    PRO A   30         13        -0.16                     
CISPEP  27 ILE A   26    PRO A   27         14        -0.10                     
CISPEP  28 ASN A   29    PRO A   30         14        -0.13                     
CISPEP  29 ILE A   26    PRO A   27         15        -0.22                     
CISPEP  30 ASN A   29    PRO A   30         15        -0.20                     
CISPEP  31 ILE A   26    PRO A   27         16        -0.11                     
CISPEP  32 ASN A   29    PRO A   30         16        -0.11                     
CISPEP  33 ILE A   26    PRO A   27         17        -0.19                     
CISPEP  34 ASN A   29    PRO A   30         17        -0.02                     
CISPEP  35 ILE A   26    PRO A   27         18        -0.17                     
CISPEP  36 ASN A   29    PRO A   30         18        -0.12                     
CISPEP  37 ILE A   26    PRO A   27         19        -0.20                     
CISPEP  38 ASN A   29    PRO A   30         19        -0.18                     
CISPEP  39 ILE A   26    PRO A   27         20        -0.01                     
CISPEP  40 ASN A   29    PRO A   30         20        -0.15                     
CRYST1    1.000    1.000    1.000  90.00  90.00  90.00 P 1           1          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      1.000000  0.000000  0.000000        0.00000                         
SCALE2      0.000000  1.000000  0.000000        0.00000                         
SCALE3      0.000000  0.000000  1.000000        0.00000